United States · FDA National Drug Code directory

METRONIDAZOLE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70771-1045_b7d7886c-cdcf-4200-8149-d99b6b135183
Product NDC: 70771-1045
Form: TABLET
Composition / generic term: METRONIDAZOLE
Labeler: Zydus Lifesciences Limited
Marketing category: ANDA
Marketing start / end (source format): 20190223
Source listing expiry: 20261231

Source-listed ingredients

METRONIDAZOLE — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (70771-1045-1) · 70771-1045-1
500 TABLET in 1 BOTTLE (70771-1045-5) · 70771-1045-5
250 TABLET in 1 BOTTLE (70771-1045-8) · 70771-1045-8

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →